ELIT-AML : Comparative phase II trial of Early prophylactic donor Lymphocyte Infusion after allogeneic hematopoietic stem cell Transplantation for patients with Acute Myeloid Leukemia

Etude randomisée de phase II
Investigateur : Dr Raynier Devillier
Promoteur : IPC
 Synopsis

En cours
Back to Top